PharmAla, the world's first publicly-traded manufacturer of GMP MDMA, has contracted with Clerkenwell Health, a UK-based CRO and Clinical Trial site, to provide regulatory support for both US FDA and UK MHRA applications
PharmAla Contracts with Clerkenwell to bring safer MDMA analogue to US, UK
Provided Content: Content provided by Newswire.ca. The Globe and Mail was not involved, and material was not reviewed prior to publication.
